1-3 of 3
Tuna Mutis, MDPhD
Close
Sort by
Journal Articles

CD38 Chimeric Antigen Receptor Engineered T Cells As Therapeutic Tools for Multiple Myeloma

Esther Drent, Richard Groen, PhD, Willy A. Noort, PhD, Jeroen Lammerts van Bueren, PhD, Paul W.H.I. Parren, PhD, Jurgen H Kuball, MDPhD, Zsolt Sebestyen, PhD, Niels W.C.J. van de Donk, MDPhD, Anton C. Martens, PhD, Henk M. Lokhorst, MDPhD, Tuna Mutis, MDPhD
Journal: Blood
Blood (2014) 124 (21): 4759.
https://doi.org/10.1182/blood.V124.21.4759.4759
Published: 2014
Journal Articles

Identification of Minor Histocompatibility Antigens Based on the 1000 Genomes Project for Application in Therapeutic Dendritic Cell Vaccination

Rimke Oostvogels, MD, Henk M. Lokhorst, MDPhD, Maureen van Elk, Kelly van den Oudenalder, Eric Spierings, PhD, Monique C. Minnema, MDPhD, Tuna Mutis, MDPhD, Robbert Spaapen, PhD
Journal: Blood
Blood (2014) 124 (21): 2418.
https://doi.org/10.1182/blood.V124.21.2418.2418
Published: 2014
Journal Articles

Modulation of CD38 Expression Levels on Multiple Myeloma Tumor Cells By All- Trans Retinoic Acid Improves the Efficacy of the Anti-CD38 Monoclonal Antibody Daratumumab

Inger S. Nijhof, MD, Henk M. Lokhorst, MDPhD, Berris van Kessel, Richard W.J. Groen, PhD, Anton C. Martens, PhD, Parul Doshi, PhD, Saskia K. Klein, MDPhD, Tuna Mutis, MDPhD, Kate Sasser, Niels W.C.J. van de Donk, MDPhD
Journal: Blood
Blood (2014) 124 (21): 2096.
https://doi.org/10.1182/blood.V124.21.2096.2096
Published: 2014